SecBot SecBot
SECBOTREPLAY Home › Report › ABT

ABT · The court denied plaintiffs' motion for sanctions against Abbott and…

ABBOTT LABORATORIES · COURT-RULING filed Apr 21, 2026 at 20:00 ET

At the news

NEUTRALIMPACT 4/10

COURT-RULING filed Apr 21, 2026 at 20:00 ET

The court denied plaintiffs' motion for sanctions against Abbott and denied their request to reopen discovery in this infant formula product liability case. The court granted only limited post-discovery production of Abbott's written response to the FDA's 2022 Establishment Inspection Report and a brief supplemental briefing schedule on Abbott's pending summary judgment motion. The ruling is a modest procedural win for Abbott: the case remains alive but plaintiffs were denied the broad discovery expansion they sought, and the core summary judgment motion is still pending with near-term resolution likely.

  • Plaintiffs' motion for sanctions against Abbott was DENIED for failure to follow local court rules
  • Plaintiffs' request to reopen discovery for six months was DENIED
  • Court ordered Abbott to produce its written response to the FDA's 2022 EIR by May 5, 2026
  • Abbott's summary judgment motion is stayed for supplemental briefing; decision still pending

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access